TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive In Brief: Jack White Resigns As Director Of Howard Cancer Center; Roberson to Retire From Centers Program June 1, 1984
TCL Archive FCRF Contracts Hit $40.3 Million With Transfer Of Labs From NIH, Elsewhere October 8, 1982